Short‐term real‐world experience with baricitinib treatment in Danish adults with moderate–severe atopic dermatitis
2022; Wiley; Volume: 37; Issue: 4 Linguagem: Inglês
10.1111/jdv.18804
ISSN1468-3083
AutoresIda Vittrup, Jesper Elberling, Lone Skov, Kristina Sophie Ibler, Gregor B. E. Jemec, Charlotte G. Mørtz, Rasmus Overgaard Bach, Carsten Bindslev‐Jensen, Maiken Glud Dalager, Alexander Egeberg, Maria R. Kamstrup, Mette Deleuran, Christian Vestergaard, Jacob P. Thyssen,
Tópico(s)Immune Cell Function and Interaction
ResumoJournal of the European Academy of Dermatology and VenereologyVolume 37, Issue 4 p. e543-e546 LETTER TO THE EDITOR Short-term real-world experience with baricitinib treatment in Danish adults with moderate–severe atopic dermatitis Ida Vittrup, Ida Vittrup orcid.org/0000-0002-3192-6135 Department of Dermatology, Copenhagen University Hospital – Bispebjerg and Frederiksberg, Copenhagen, Denmark Department of Dermatology and Allergy, Copenhagen University Hospital – Herlev and Gentofte, Copenhagen, DenmarkSearch for more papers by this authorJesper Elberling, Jesper Elberling orcid.org/0000-0002-8925-4722 Department of Dermatology and Allergy, Copenhagen University Hospital – Herlev and Gentofte, Copenhagen, DenmarkSearch for more papers by this authorLone Skov, Lone Skov orcid.org/0000-0002-4784-9680 Department of Dermatology and Allergy, Copenhagen University Hospital – Herlev and Gentofte, Copenhagen, DenmarkSearch for more papers by this authorKristina Sophie Ibler, Kristina Sophie Ibler orcid.org/0000-0002-5324-1591 Department of Dermatology, Zealand University Hospital, University of Copenhagen, Roskilde, DenmarkSearch for more papers by this authorGregor B. E. Jemec, Gregor B. E. Jemec orcid.org/0000-0002-0712-2540 Department of Dermatology, Zealand University Hospital, University of Copenhagen, Roskilde, DenmarkSearch for more papers by this authorCharlotte G. Mortz, Charlotte G. Mortz orcid.org/0000-0001-8710-0829 Department of Dermatology and Allergy Center, Odense University Hospital, Odense, DenmarkSearch for more papers by this authorRasmus Overgaard Bach, Rasmus Overgaard Bach orcid.org/0000-0003-2502-3551 Department of Dermatology and Allergy Center, Odense University Hospital, Odense, DenmarkSearch for more papers by this authorCarsten Bindslev-Jensen, Carsten Bindslev-Jensen orcid.org/0000-0002-8940-038X Department of Dermatology and Allergy Center, Odense University Hospital, Odense, DenmarkSearch for more papers by this authorMaiken Glud Dalager, Maiken Glud Dalager Department of Dermatology, Aalborg University Hospital, Aalborg, DenmarkSearch for more papers by this authorAlexander Egeberg, Alexander Egeberg orcid.org/0000-0001-8257-1816 Department of Dermatology, Copenhagen University Hospital – Bispebjerg and Frederiksberg, Copenhagen, DenmarkSearch for more papers by this authorMaria Kamstrup, Maria Kamstrup Department of Dermatology, Copenhagen University Hospital – Bispebjerg and Frederiksberg, Copenhagen, DenmarkSearch for more papers by this authorMette Deleuran, Mette Deleuran orcid.org/0000-0003-0593-9925 Department of Dermatology, Aarhus University Hospital, Aarhus, DenmarkSearch for more papers by this authorChristian Vestergaard, Christian Vestergaard orcid.org/0000-0001-6485-3158 Department of Dermatology, Aarhus University Hospital, Aarhus, DenmarkSearch for more papers by this authorJacob P. Thyssen, Corresponding Author Jacob P. Thyssen [email protected] orcid.org/0000-0003-3770-1743 Department of Dermatology, Copenhagen University Hospital – Bispebjerg and Frederiksberg, Copenhagen, Denmark Correspondence Jacob P. Thyssen, Department of Dermatology and Venereology, Copenhagen University Hospital – Bispebjerg and Frederiksberg, Copenhagen, Denmark. Email: [email protected]Search for more papers by this author Ida Vittrup, Ida Vittrup orcid.org/0000-0002-3192-6135 Department of Dermatology, Copenhagen University Hospital – Bispebjerg and Frederiksberg, Copenhagen, Denmark Department of Dermatology and Allergy, Copenhagen University Hospital – Herlev and Gentofte, Copenhagen, DenmarkSearch for more papers by this authorJesper Elberling, Jesper Elberling orcid.org/0000-0002-8925-4722 Department of Dermatology and Allergy, Copenhagen University Hospital – Herlev and Gentofte, Copenhagen, DenmarkSearch for more papers by this authorLone Skov, Lone Skov orcid.org/0000-0002-4784-9680 Department of Dermatology and Allergy, Copenhagen University Hospital – Herlev and Gentofte, Copenhagen, DenmarkSearch for more papers by this authorKristina Sophie Ibler, Kristina Sophie Ibler orcid.org/0000-0002-5324-1591 Department of Dermatology, Zealand University Hospital, University of Copenhagen, Roskilde, DenmarkSearch for more papers by this authorGregor B. E. Jemec, Gregor B. E. Jemec orcid.org/0000-0002-0712-2540 Department of Dermatology, Zealand University Hospital, University of Copenhagen, Roskilde, DenmarkSearch for more papers by this authorCharlotte G. Mortz, Charlotte G. Mortz orcid.org/0000-0001-8710-0829 Department of Dermatology and Allergy Center, Odense University Hospital, Odense, DenmarkSearch for more papers by this authorRasmus Overgaard Bach, Rasmus Overgaard Bach orcid.org/0000-0003-2502-3551 Department of Dermatology and Allergy Center, Odense University Hospital, Odense, DenmarkSearch for more papers by this authorCarsten Bindslev-Jensen, Carsten Bindslev-Jensen orcid.org/0000-0002-8940-038X Department of Dermatology and Allergy Center, Odense University Hospital, Odense, DenmarkSearch for more papers by this authorMaiken Glud Dalager, Maiken Glud Dalager Department of Dermatology, Aalborg University Hospital, Aalborg, DenmarkSearch for more papers by this authorAlexander Egeberg, Alexander Egeberg orcid.org/0000-0001-8257-1816 Department of Dermatology, Copenhagen University Hospital – Bispebjerg and Frederiksberg, Copenhagen, DenmarkSearch for more papers by this authorMaria Kamstrup, Maria Kamstrup Department of Dermatology, Copenhagen University Hospital – Bispebjerg and Frederiksberg, Copenhagen, DenmarkSearch for more papers by this authorMette Deleuran, Mette Deleuran orcid.org/0000-0003-0593-9925 Department of Dermatology, Aarhus University Hospital, Aarhus, DenmarkSearch for more papers by this authorChristian Vestergaard, Christian Vestergaard orcid.org/0000-0001-6485-3158 Department of Dermatology, Aarhus University Hospital, Aarhus, DenmarkSearch for more papers by this authorJacob P. Thyssen, Corresponding Author Jacob P. Thyssen [email protected] orcid.org/0000-0003-3770-1743 Department of Dermatology, Copenhagen University Hospital – Bispebjerg and Frederiksberg, Copenhagen, Denmark Correspondence Jacob P. Thyssen, Department of Dermatology and Venereology, Copenhagen University Hospital – Bispebjerg and Frederiksberg, Copenhagen, Denmark. Email: [email protected]Search for more papers by this author First published: 04 December 2022 https://doi.org/10.1111/jdv.18804Citations: 2Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1Simpson EL, Lacour JP, Spelman L, Galimberti R, Eichenfield LF, Bissonnette R, et al. Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials. Br J Dermatol. 2020; 183: 242–55. 2Reich K, Kabashima K, Peris K, Silverberg JI, Eichenfield LF, Bieber T, et al. Efficacy and safety of baricitinib combined with topical corticosteroids for treatment of moderate to severe atopic dermatitis: a randomized clinical trial. JAMA Dermatol. 2020; 156: 1333–43. 3Hedegaard Pliess Larsen H, Vittrup I, Frier Ruge I, Elberling J, Skov L, Ibler K, et al. Severe and ChRonic Atopic dermatitis Treatment CoHort (SCRATCH): a Danish Real-World Evidence Atopic Dermatitis Treatment Registry. Acta Derm Venereol. 2022; 102: adv00760. 4Uchiyama A, Fujiwara C, Inoue Y, Sichiro M. Real-world effectiveness and safety of baricitinib in Japanese patients with atopic dermatitis: a single-center retrospective study. J Dermatol. 2022; 49: 469–71. 5Vittrup I, Krogh NS, Larsen HHP, Elberling J, Skov L, Ibler K, et al. A nationwide 104 weeks real-world study of dupilumab in adults with atopic dermatitis: ineffectiveness in head-and-neck dermatitis. J Eur Acad Dermatol Venereol. 2022; Accepted. 6Rogner D, Biedermann T, Lauffer F. Treatment of atopic dermatitis with baricitinib: first real-life experience. Acta Derm Venereol. 2022; 102: 1–3. Citing Literature Volume37, Issue4April 2023Pages e543-e546 ReferencesRelatedInformation
Referência(s)